NCT01984541View on ClinicalTrials.gov

To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction.

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

September 30, 2014

Conditions
Allergy to Pollen
Interventions
BIOLOGICAL

Artemisia vulgaris

Four concentrations of Artemisia vulgaris allergen extract, together with a positive and negative control will be tested in every patient in duplicate on the volar surface of the forearm.

Trial Locations (2)

03314

Hospital de La Agencia Valenciana de Salud Vega Baja, Orihuela

08036

Hospital Clinic de Barcelona, Barcelona

Sponsors
All Listed Sponsors
lead

Laboratorios Leti, S.L.

INDUSTRY

NCT01984541 - To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction. | Biotech Hunter | Biotech Hunter